Explore articles, research, and perspectives from the International Perfusion Association.
A Cleveland Clinic case report describes beating-heart redo mitral surgery for severe hemolysis after leak-plug placement, with rapid laboratory improvement.
A focused review examines cardioplegia in aortic stenosis, including ventricular hypertrophy, solution choice, temperature, delivery, dosing, and redosing.
A 12-patient Mayo Clinic series reports successful Impella-assisted high-risk PCI followed by TAVR in one session, with important limitations and inconsistent pacemaker reporting.
A JACC review explores AI in valve screening, imaging, procedural planning, and risk prediction, while emphasizing validation, human oversight, and the gap between technical
A meta-analysis of six observational studies compared beating-heart and arrested-heart techniques for isolated tricuspid valve surgery. No significant differences were detected in pacemaker implantation,
A 155-pair study links miniAVR with fewer stroke/TIA events, but rare outcomes, residual confounding, and unequal follow-up limit causal conclusions.
TOTO-TAVI compares 6,193 patients in Japan and France: mortality, bleeding, pacemakers, small annuli, and the limits of an observational comparison.
A post hoc PRO-TAVI analysis explores coronary disease complexity, PCI timing, and bleeding in 466 TAVR patients. Subgroup findings require confirmation.
A 17-centre registry analysis of 502 redo mitral operations through right minithoracotomy reports 7.6% in-hospital mortality and 3% conversion to sternotomy. Compared with cardioplegia,
A randomized trial in Nepal compared pulsatile and non-pulsatile cardiopulmonary bypass in elective atrial septal defect closure and mitral valve replacement. Among 77 analyzed
A retrospective cohort of 200 adults describes normothermic cardiopulmonary bypass guided by indexed flow, cerebral oximetry, and oxygen delivery, with vasopressors reserved for clinical
A Colombian study of 179 adults undergoing isolated aortic valve replacement found lower modeled costs with Del Nido than Custodiol cardioplegia. Thirty-day survival was
